Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 12, 2003, Pages 943-950

  Yan, Lin ^a   Zhang, Qihang ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

cAMP; Cardiac myocyte; cGMP; cGMP protein kinase; Rabbit; Thyroxine induced hypertrophy

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; 8 BROMO CYCLIC AMP; BETA PHENYL 1,N2 ETHENO 8 BROMOGUANOSINE 3',5' MONOPHOSPHOROTHIOATE; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; PHOSPHOROTHIOIC ACID DERIVATIVE; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ELECTRODE; ENZYME ACTIVITY; ENZYME MECHANISM; HEART CONTRACTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HORMONE ACTION; MUSCLE CELL; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN PHOSPHORYLATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BODY WEIGHT; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; GUANOSINE; HEART VENTRICLES; HYPERTROPHY; INJECTIONS, INTRAMUSCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; ORGAN SIZE; OXYGEN CONSUMPTION; PHOSPHOPROTEINS; PHOSPHORYLATION; RABBITS; STIMULATION, CHEMICAL; THYROXINE; TIME FACTORS;

EID: 0348047572     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2003.03936.x     Document Type: Article

References (33)

1. Lohmann SM, Fischmeister R, Walter U. Signal transduction by cGMP in heart. Basic Res. Cardiol. 1991; 86: 503-14.
2. Murad F. The nitric oxide-cGMP signal transduction system for intracellular and intercellular communication. Rec. Prog. Horm. Res. 1994; 49: 239-48.
3. 2+ in intact cardiac myocytes. Circ. Res. 1994; 74: 970-8.
4. Sperelakis N, Tohse N, Ohya Y, Masuda H. Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells. Adv. Pharmacol. 1994; 26: 217-52.
5. Lincoln TM, Komalavilas P, Cornell TL. Pleiotropic regulation of vascular smooth muscle tone by cGMP-dependent protein kinase. Hypertension 1994; 23: 1141-7.
6. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl Acad. Sci. USA 1991; 88: 1197-201.
7. Wahler GM, Dollinger SH. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 1995; 268: C45-54.
8. Straznicka M, Gong G, Yan L, Scholz PM, Weiss HR. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes. J. Cardiovasc. Pharmacol. 1999; 34: 229-36.
9. Haddad GE, Sperelakis N, Walter G. Regulation of the calcium slow channel by cyclic GMP dependent protein kinase in chick heart cells. Mol. Cell. Biochem. 1995; 148: 89-94.
10. 2+ current in rat ventricular myocytes. Circ. Res. 1995; 77: 803-12.
11. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev. Physiol. Biochem. Pharmacol. 1989; 113: 41-88.
12. Naim KL, Rabindranauth P, Weiss HR, Tse J, Leone Jr RJ, Scholz PM. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts. Can. J. Physiol. Pharmacol. 1998; 76: 605-12.
13. Cornell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 1994; 267: C1405-13.
14. Yan L, Lee H, Huang MW, Scholz PM, Weiss HR. Opposing functional effects of cyclic GMP and cyclic AMP may act through protein phosphorylation in rabbit cardiac myocytes. J. Autonom. Pharmacol. 2000; 20: 111-21.
15. Chilian WM, Wangler RD, Peters KG, Tomanek RJ, Marcus ML. Thyroxine-induced left ventricular hypertrophy in the rat. Circ. Res. 1985; 57: 591-8.
16. Eliades D, Weiss HR. Role of beta-adrenoceptors in the hypertrophic response to thyroxine. J. Cardiovasc. Pharmacol. 1989; 14: 58-65.
17. 4-induced cardiac hypertrophy. Am. J. Physiol. 1995; 268: H686-H691.
18. Weiss HR, Tse J. Myocardial metabolic and functional responses to acetylcholine are altered in thyroxine-induced cardiac hypertrophy. Can. J. Physiol. Pharmacol. 1995; 73: 729-35.
19. Crie JS, Wakeland JR, Mayhew BA, Wildenthal K. Direct anabolic effects of thyroid hormone on isolated mouse heart. Am. J. Physiol. 1983; 245: C328-33.
20. Crozatier B, Su JB, Corsin A, Bouanani NH. Specific difference in myocardial β-adrenergic receptor regulation in response to hyperthyroidism. Circ. Res. 1991; 69: 1234-43.
21. Jiang M, Xu A, Tokmakejian S, Narayanan N. Thyroid hormone-induced overexpression of functional ryanodine receptors in the rabbit heart. Am. J. Physiol. 2000; 278: H1429-38.
22. Seihl D, Chua BH, Lautensack-Besler N, Morgan HE. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of the heart. Am. J. Physiol. 1985; 248: C309-19.
23. 4 cardiac myocytes. Eur. J. Pharmacol. 2001; 421: 23-30.
24. Sugden PH, Bogoyevitch MA. Intracellular signaling through protein kinases in the heart. Cardiovasc. Res. 1995; 30: 478-92.
25. Yan L, Gong GX, Scholz PM, Tse J, Weiss HR. Negative metabolic effects of cyclic GMP in quiescent cardiac myocytes are not related to L-type calcium channel activity. Res. Exp. Med. 1998; 198: 123-32.
26. 2+ current and elicited by withdrawal of acetylcholine in atrial myocytes. J. Gen. Physiol. 1998; 111: 113-25.
27. 2+ channels by cyclic AMP and cyclic GMP-dependent protein kinase in Pleurodeles oocytes. Mol. Cell. Biochem. 1997; 168: 155-61.
28. Gong G, Weiss HR, Tse J, Scholz PM. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation. Eur. J. Pharmacol. 1998; 344: 299-305.
29. 2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels. Res. Exp. Med. 1998; 198: 109-21.
30. Hove-Madsen L, Mery PF, Jurevicius JAV, Skeberdis AV, Fischmeister R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res. Cardiol 1996; 91 (Suppl. 2): 1-8.
31. Gill GN, Holdy KE, Walton GM, Kanstein CB. Purification and characterization of 3′,5′-cyclic GMP-dependent protein kinase. Proc. Natl Acad. Sci. USA 1976; 73: 3918-22.
32. Labrie F, Labrie S, Courte C. Adenosine 3′,5′-monophosphate- dependent protein kinase from bovine anterior pituitary gland. I. Properties. J. Biol. Chem. 1971; 246: 7293-302.
33. Eckly-Michel A, Martin V, Lungier C. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol. 1997; 122: 158-64.